MF
IONS icon

Montis Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Montis Financial’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$203K Hold
2,700
– – 0.04% 149
2025
Q4 		$214K Buy
+2,700
New +$203K 0.04% 149

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Montis Financial's IONS Position: Q1 2026 in Review

Montis Financial held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 2,700 shares worth $203K. The position accounts for 0.04% of the portfolio, ranked #149.

Montis Financial first reported a position in IONS in Q4 2025 and has held it in 2 quarters since. The position peaked at $214K in Q4 2025. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Montis Financial held 2,700 shares of Ionis Pharmaceuticals worth $203K as of Q1 2026.
  • Montis Financial left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
  • Ionis Pharmaceuticals made up 0.04% of Montis Financial's portfolio in Q1 2026, its #149 holding.
  • Montis Financial first reported a position in Ionis Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Montis Financial's Ionis Pharmaceuticals position peaked at $214K in Q4 2025.
  • 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Montis Financial's 13F filing for Q1 2026, filed 11 May 2026.